| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB10201-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB10203-SP | |||
| Carrier Free | FAB10203R-100UG | |||
| Carrier Free | FAB10203V-100UG | |||
| Carrier Free | FAB10203G-100UG | |||
| Carrier Free | FAB10203S-100UG | |||
| Carrier Free | FAB10203U-100UG | |||
| Carrier Free | FAB10203N-100UG | |||
| Carrier Free | FAB10203T-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | SK0223 | |||
| Carrier Free | PK0223 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-38730-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75901SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB10202-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB2231R-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NB110-97867-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52660-0.025mg | |||
![N/A CD25/IL-2R alpha [HRP]](http://images.novusbio.com/fullsize/qk0223_human-cd25-il-2-r-alpha-quickit-elisa-kit-3132025133111..png "N/A CD25/IL-2R alpha [HRP]")
![N/A CD25/IL-2R alpha [HRP]](http://images.novusbio.com/fullsize/qk0223_human-cd25-il-2-r-alpha-quickit-elisa-kit-3132025133142..png)
![Immunohistochemistry-Paraffin: CD25/IL-2R alpha Antibody [NBP2-38730] - CD25/IL-2 R alpha Antibody [NBP2-38730] - Analysis in human lymph node and cerebral cortex tissues. Corresponding IL2RA RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-Immunohistochemistry-Paraffin-NBP2-38730-img0006.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD25/IL-2R alpha Antibody [NBP2-38730] - CD25/IL-2 R alpha Antibody [NBP2-38730] - Analysis in human lymph node and cerebral cortex tissues. Corresponding IL2RA RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody [NBP2-38730] - Staining of human lymph node shows strong membranous positivity in non-germinal center cells.](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-Immunohistochemistry-Paraffin-NBP2-38730-img0009.jpg)
![Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody [NBP2-38730] - Staining of human cerebral cortex shows no positivity in neurons as expected.](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-Immunohistochemistry-Paraffin-NBP2-38730-img0007.jpg)
![Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody [NBP2-38730] - Staining of human kidney shows no positivity in cells in tubules as expected.](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-Immunohistochemistry-Paraffin-NBP2-38730-img0008.jpg)
![Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody [NBP2-38730] - Staining of human testis shows no positivity in cells in seminiferous ducts as expected.](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-Immunohistochemistry-Paraffin-NBP2-38730-img0010.jpg)
![Western Blot: CD25/IL-2R alpha Antibody (Daclizumab) [NBP2-75901] - Mouse lipocyte (lane 1), mouse spleen (lane 2), mouse thymus (lane 3), mouse lymph node (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75901 at 1.5 ug/ml before being detected by a secondary antibody. The expected band size (31 kDa) is seen in the human-derived sample, as well as further bands that are specific to human.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Daclizumab-Western-Blot-NBP2-75901-img0002.jpg "Western Blot: CD25/IL-2R alpha Antibody (Daclizumab) [NBP2-75901] - Mouse lipocyte (lane 1), mouse spleen (lane 2), mouse thymus (lane 3), mouse lymph node (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75901 at 1.5 ug/ml before being detected by a secondary antibody. The expected band size (31 kDa) is seen in the human-derived sample, as well as further bands that are specific to human.")
![Immunohistochemistry: CD25/IL-2R alpha Antibody (Daclizumab) [NBP2-75901] - Formalin fixed rat spleen slices were were stained with NBP2-75901 at 5 ug/ml.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Daclizumab-Immunohistochemistry-NBP2-75901-img0001.jpg)
![Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody (AP-MAB0710) [NB110-97867] - Formalin fixed and paraffin embedded mouse spleen tissue section was subjected to immunohistochemistry staining of CD25.](http://images.novusbio.com/fullsize/CD25-IL-2-R-alpha-Antibody-AP-MAB0710-Immunohistochemistry-Paraffin-NB110-97867-img0003.jpg "Immunohistochemistry-Paraffin: CD25/IL-2 R alpha Antibody (AP-MAB0710) [NB110-97867] - Formalin fixed and paraffin embedded mouse spleen tissue section was subjected to immunohistochemistry staining of CD25.")
![Flow Cytometry: CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric [NBP2-52660] - CD25/IL-2 R alpha Antibody (Daclizumab) [NBP2-52660] - Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Daclizumab (NBP2-52660, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Daclizumab-Chimeric-Flow-Cytometry-NBP2-52660-img0006.jpg "Flow Cytometry: CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric [NBP2-52660] - CD25/IL-2 R alpha Antibody (Daclizumab) [NBP2-52660] - Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Daclizumab (NBP2-52660, panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Flow Cytometry: CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric [NBP2-52660] - Cynomolgus monkey lymphocytes were stained with an isotype control (red) or the rabbit-chimeric version of Daclizumab (NBP2-52660, blue) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody (ab150073) and cells analysed on a FlowJo single-cell flow cytometer.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Daclizumab-Chimeric-Flow-Cytometry-NBP2-52660-img0004.jpg)
![Flow Cytometry: CD25/IL-2R alpha Antibody (Daclizumab) - Chimeric [NBP2-52660] - CD25/IL-2 R alpha Antibody (Daclizumab) [NBP2-52660] - Rhesus monkey lymphocytes were stained with an isotype control (red) or the rabbit-chimeric version of Daclizumab (NBP2-52660, blue) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody (ab150073) and cells analysed on a FlowJo single-cell flow cytometer.](http://images.novusbio.com/fullsize/CD25-IL-2R-alpha-Antibody-Daclizumab-Chimeric-Flow-Cytometry-NBP2-52660-img0005.jpg)